The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

A breakthrough in breast cancer research is showing promising signs in the development of a vaccine for the disease. Anixa Biosciences, Inc. is working with the Cleveland Clinic to ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Specialist Consultant Paediatrician and Honorary Senior Fellow, Postgraduate Institute of Medicine, University of Colombo, ...

In a new collaboration that could transform how cancer is treated, OCCAM Immune-a Mount Sinai initiative focused on ...

Beth Israel Deaconess Medical Center names Dr. Elizabeth Mittendorf as Chief of new Breast Surgery Division, joining the Department of Surgery this fall.

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion in a deal designed to bolster the buyer’s cardiovascular treatment pipeline with Verve’s gene editing therapies, led by ...